Smallcap biotech Jaguar Health’s stock jumps as it launches treatment for a painful side effect of cancer treatment
Oct 16, 2024
The stock of small-cap biotech Jaguar Health Inc. rose 7% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer patients.
https://www.marketwatch.com/story/small-cap-biotech-jaguar-healths-stock-jumps-4-as-it-launches-gelclair-treatment-for-oral-mucositis-in-cancer-patients-742db94d?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service